Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.
The ability of genetically detoxified lipopolysaccharide (LPS) to stimulate adaptive immune responses is an ongoing area of investigation with significant consequences for the development of safe and effective bacterial vaccines and adjuvants. One approach to genetic detoxification is the deletion of genes whose products modify LPS. The msbB1 and msbB2 genes, which encode late acyltransferases, were deleted in the Shigella flexneri 2a human challenge strain 2457T to evaluate the virulence, inflammatory potential, and acquired immunity induced by strains producing underacylated lipid A. Consistent with a reduced endotoxic potential, S. flexneri 2a msbB mutants were attenuated in an acute mouse pulmonary challenge model. Attenuation correlated with decreases in the production of proinflammatory cytokines and in chemokine release without significant changes in lung histopathology. The levels of specific proinflammatory cytokines (interleukin-1beta [IL-1beta], macrophage inflammatory protein 1alpha [MIP-1alpha], and tumor necrosis factor alpha [TNF-alpha]) were also significantly reduced after infection of mouse macrophages with either single or double msbB mutants. Surprisingly, the msbB double mutant displayed defects in the ability to invade, replicate, and spread within epithelial cells. Complementation restored these phenotypes, but the exact nature of the defects was not determined. Acquired immunity and protective efficacy were also assayed in the mouse lung model, using a vaccination-challenge study. Both humoral and cellular responses were generally robust in msbB-immunized mice and afforded significant protection from lethal challenge. These data suggest that the loss of either msbB gene reduces the endotoxicity of Shigella LPS but does not coincide with a reduction in protective immune responses.
Ranallo
Ryan T
RT
Division of Bacterial and Rickettsial Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA. ryan.ranallo@amedd.army.mil
Kaminski
Robert W
RW
George
Tonia
T
Kordis
Alexis A
AA
Chen
Qing
Q
Szabo
Kathleen
K
Venkatesan
Malabi M
MM
D056704:Adaptive Immunity; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D004756:Enterobacteriaceae Infections / Q000382:microbiology*; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D007249:Inflammation / Q000382:microbiology*; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000382:microbiology*; D051379:Mice; D009154:Mutation; D012763:Shigella flexneri / Q000235:genetics* / Q000378:metabolism*; D013154:Spleen / Q000166:cytology; D014774:Virulence
D001426:Bacterial Proteins; D016207:Cytokines